Skip to main content
Veterinary Medicines

Selevit ενέσιμο διάλυμα για βοοειδή,πρόβατα,χοίρους και άλογα.

Authorised
  • Adenosine
  • ALPHA-TOCOPHEROL
  • Cyanocobalamin
  • Selenium
  • SORBITOL (E420)

Product identification

Medicine name:
Selevit ενέσιμο διάλυμα για βοοειδή,πρόβατα,χοίρους και άλογα.
Active substance:
  • Adenosine
  • ALPHA-TOCOPHEROL
  • Cyanocobalamin
  • Selenium
  • SORBITOL (E420)
Target species:
  • Cattle (calf)
  • Sheep (lamb)
  • Horse
  • Pig
Route of administration:
  • Intramuscular use
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Adenosine
    5.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • ALPHA-TOCOPHEROL
    70.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Cyanocobalamin
    0.10
    milligram(s)
    /
    1.00
    millilitre(s)
  • Selenium
    0.15
    milligram(s)
    /
    1.00
    millilitre(s)
  • SORBITOL (E420)
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle (calf)
    • Sheep (lamb)
    • Horse
    • Pig
  • Intravenous use
    • Cattle (calf)
    • Sheep (lamb)
    • Pig
    • Horse
  • Subcutaneous use
    • Cattle (calf)
    • Sheep (lamb)
    • Pig
    • Horse
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA11AA03
Authorisation status:
  • Valid
Authorised in:
  • Cyprus
Available in:
  • Cyprus
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Fatro S.p.A.
Responsible authority:
  • Veterinary Services, Ministry Of Agriculture, Natural Resources And Environment
Authorisation number:
  • 10307
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 8/12/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."